25 Oct 2023 myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off the shelf cancer vaccine immunotherapeutics Member news
25 Oct 2023 4TISSUE strengthens leadership team by welcoming Chief Executive Officer (CEO) Benoit Moreaux, DVM, PhD, PMP Member news
23 Oct 2023 Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Member news
19 Oct 2023 Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission Member news
19 Oct 2023 Belgian researchers demonstrate that the gut microbiome can help predict the course of multiple sclerosis Member news
18 Oct 2023 Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome Member news
17 Oct 2023 mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board Member news
16 Oct 2023 Biocartis honors Breast Cancer Awareness Month with launch of Breast Cancer Portfolio Member news
12 Oct 2023 Biocartis announces expansion of its collaboration with APIS Assay Technologies to commercialize the APIS ESR1 Mutations Kit Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
